价格

Approvals/FDA/Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium

Approved

HUMAN PRESCRIPTION DRUG LABEL

26a3cdc380ac86fa

Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium

Sandoz Inc🇺🇸 United States

FDA Page

Effective Date: May 19, 2023
Approval ID: 58cd12d3-39b1-4375-b7e0-09ba2378a52b
Products: 1 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS safely and effectively. See full prescribing information for DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM. DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS, for oral use.Initial U.S. Approval: 2010

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.